The Metabolic Syndrome From Pathophysiology to Novel Treatment Strategies
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
1-24
Author(s):
Cynthia Arbeeny, Robert Sacchiero and Michael Booker
Direct Vascular Targets For Atherosclerosis Prevention
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
39-46
Author(s):
Brian R. Krause, Bruce J. Auerbach and Thomas M. A. Bocan
Correspondence Section
Journal:
Current Drug Targets
Volume:
2
Page:
107-108
Author(s):
I. A. Jagroop and D. P. Mikhailidis
Current Trends in the Development of New Antidepressants
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
89-100
Author(s):
Pal Pacher, Eva Kohegyi, Valeria Kecskemeti and Susanna Furst
Leptin Transport Across the Blood-Brain Barrier: Implications for the Cause and Treatment of Obesity
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
125-133
Author(s):
William A. Banks
SUBJECT INDEX TO VOLUME 4 Current Organic Chemistry
Journal:
Current Organic Chemistry
Volume:
5
Page:
115-126
Author(s):
Targets for Steroid Hormone Mediated Actions of Periodontal Pathogens, Cytokines and Therapeutic Agents Some Implications on Tissue Turnover in the Periodontium
Journal:
Current Drug Targets
Volume:
1
Page:
309-325
Author(s):
M. Soory
Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Journal:
Current Drug Targets
Volume:
1
Page:
247-260
Author(s):
M. A. Khan, R. C. Calvert, M. E. Sullivan, C. S. Thomson, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis
New Developments in Anti-Platelet Therapies Potential Use of CD39/Vascular ATP Diphosphohydrolase in Thrombotic Disorders
Journal:
Current Drug Targets
Volume:
1
Page:
285-296
Author(s):
Imrana Qawi and Simon C. Robson
Current Problems with Non-Specific COX Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
1693-1724
Author(s):
Patricia McGettigan and David Henry